🇰🇷 KRXHealthcareMarket Closed
HLB Inc.
028300 · HLB
₩75,000
+₩2,200 (+3.02%)
Price Chart (Mock)
About
Bio company developing anticancer drug rivoceranib. High volatility on FDA approval expectations. Pipeline results are key catalyst.
P/E Ratio
-42.5x
Market Cap
₩8.9T
52W High
₩98,000
52W Low
₩45,000
Volume
4.5M
Sector
Healthcare
🔗Related Stocks
⚠️ This information does not constitute investment advice. Investment decisions should be made at your own judgment and responsibility. All data and analysis provided on this platform are for reference only.